• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Ramucirumab Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759574

MBS5759574 is an inhibitor targeting Ramucirumab. Ramucirumab is a human VEGFR-2 antagonist for the treatment,of solid tumors. More details

Please Inquire
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Ramucirumab, Inhibitor
Full Product Name
Ramucirumab
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
6369.07
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C285H434N74O88S2
CAS Number
947687-13-0
Target & IC50
VEGFR2

Product References and Citations for Ramucirumab, inhibitor

Fala L. Cyramza (Ramucirumab) Approved for the treatment,of Advanced Gastric Cancer and Metastatic Non-Small-Cell Lung Cancer. Am Health Drug Benefits. 2015 Mar;8(Spec Feature):49-53.
Fala L. Cyramza (Ramucirumab) Approved for the treatment,of Advanced Gastric Cancer and Metastatic Non-Small-Cell Lung Cancer. Am Health Drug Benefits. 2015 Mar;8(Spec Feature):49-53.

Other Notes

Small volumes of Ramucirumab, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000